BMY Aug 2025 52.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:09PM EDT. Market open.
Loading interactive chart…
- Investor's Business Daily
Bristol-Myers Squibb's Profits, Stock Price Kick Into High Gear
A Relative Strength Rating upgrade for Bristol Myers Squibb shows improving technical performance. Will it continue?
- Zacks
STTK Discontinues Cancer Program, Plans Workforce Cut, Stock Falls
Shattuck stock plunges as it discontinues the clinical development of SL-172154 for two blood cancer indications and plans to reduce the workforce by 40%.
- Zacks
PRME Stock Rises 11.8% on Collaboration With Bristol Myers
Prime Medicine collaborates with Bristol Myers Squibb for the development of T-cell therapies. Shares gain.
© 2024 Yahoo. All rights reserved.